Studies using chemical inhibitors, whole-body and tissue-specific genetic manipulations in animal models have demonstrated that abnormal RhoA/ROCK signaling contributes to the pathogenesis of obesity and type 2 diabetes. Here, RHOA is linked to obesity due to melanocortin 4 receptor deficiency.